[1] LI J, GAO X, LEI XY, et al.Study on the influencing factors of primary medical institutions for middle-aged and elderly patients with hypertension: based on the data of China health and old-age care tracking survey 2015[J]. Journal of Practical Cardio-Cerebral Pulmonary Vascular Diseases(实用心脑肺血管病杂志), 2020, 28(2): 89-93. [2] MI Y, ZHU XY, TIAN Y, et al.Study on rational drug use index and prescription behavior in 20 primary medical institutions[J]. Chinese Pharmacy(中国药事), 2017, 31(7): 795-801. [3] LI A, ZHANG B, ZHANG XM, et al.Investigation on the cognition and reporting of adverse drug reactions in 1109 primary medical institutions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(5): 289-294. [4] National Medical Products Administration. National adverse drug reaction annual monitoring report(2020 No.105)[EB/OL].(2021-03-06) [2021-12-01]. https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20210325170127199.html. [5] Drug Evaluation Center of China Food and Drug Administration.Handbook of adverse drug reaction reporting and monitoring(药品不良反应报告和监测工作手册)[EB/OL]. (2013-04-26)[2019-10-08]. http://www.cdr-adr.org.cal/was5/wed/search. [6] LIU W, JIANG HC, YAO JQ, et al.Research on traditional Chinese medicine prescription data based on association rule mining algorithm Apriori[J]. China Computer & Communication (theory edition)[信息与电脑(理论版)], 2020, 32(16): 51-55. [7] DI N, ZHENG JT, WANG PF, et al.Analysis of chronic diseases and comorbidities among elderly in Beijing[J]. Chinese General Practice(中国全科医学), 2018, 21(3): 265-268. [8] ZHOU WL, ZHANG XM, ZHANG B.Safety analysis and warning thinking of TCM decoction pieces for promoting blood circulation and removing stasis[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2016, 31(11): 4637-4643. [9] National Center for ADR Monitoring, China. Annual Report for National ADR Monitoring (2020)[EB/OL]. (2021-03-26)[2022-01-01]. https://www.cdr-adr.org.cn/center_news/202103/t20210326_48413.html. [10] SA RN, ZHANG B, LIN ZJ, et al.Pharmacovigilance of traditional Chinese medicine in pharmaceutical care in medical institutions[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(5): 422-426. [11] ZHANG B, LYU JT, ZHANG XM, et al.“Toxic-effect”cognition and pharmacovigilance thinking of traditional Chinese medicine based on“property”[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(5): 411-415. [12] Beijing Association of Cerebrovascular Disease Prevention and Treatment, expert consensus writing group of gastrodin preparation clinical application. Chinese expert consensus on clinical application of gastrodin preparation (2021)[J]. Chinese Journal of Geriatrics(中华老年医学杂志), 2021,40(4):407-415. [13] GAO Y, LIU M, SHI SZ, et al.Systematic evaluation and reevaluation of Shuxuening injection[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2021, 46(14): 3712-3721. [14] YU YQ, SHI DZ, QU H, et al.Treatment of unstable angina pectoris with Huoxue huayu traditional Chinese medicine injection: a meta-analysis[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease(中西医结合心脑血管病杂志), 2021, 19(17): 2893-2903. [15] DU J, YANG W, YI DH, et al.Analysis of combined medication of Danhong injection in treatment of coronary heart disease based on HIS “real world”[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2011, 36(20): 2821-2824. [16] LI YL, ZHANG B, ZHANG XM, et al.Clinical safety evaluation and thinking of traditional Chinese medicine based on toxic ingredients[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(6): 520-524. [17] RAN C.Signal mining and risk factors analysis of adverse reaction of iodine contrast agent[D]. Chongqing Medical University, 2020. [18] ZHANG D, LYU JT, ZHANG B, et al.Construction and application of "four- dimens ional linkage" research platform for pharmac-ovigilance of traditional Chinese medicine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(5): 416-421. [19] ZHANG XM, ZHANG B, ZHANG D, et al.Study on the risk and benefit threshold of the clinical application of traditional Chinese medicine with toxicities of simbic fever[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(6): 514-519, 524. |